Send me a link:

*Text messaging rates may apply.

 Dow Up0.17% Nasdaq Up0.44%

More On SPL.AX



News & Info


Analyst Coverage


  • Major Holders
  • Insider Transactions
  • Insider Roster


Starpharma Holdings Limited (SPL.AX)

0.59 0.00(0.00%) Jul 11, 2:11AM EDT
ProfileGet Profile for:
Starpharma Holdings Limited
Baker IDI Building
75 Commercial Road
Melbourne, VIC 3004
Australia - Map
Phone: 61 3 8532 2700
Fax: 61 3 9510 5955

Index Membership:N/A
Full Time Employees:N/A

Business Summary 

Starpharma Holdings Limited researches, develops, and commercializes dendrimer products for pharmaceutical, life-science, and other applications primarily in Australia. The company focuses on the development of its topical vaginal microbicide VivaGel as a condom coating for the treatment and prevention of bacterial vaginosis, as well as for the prevention of sexually transmitted infections, including genital herpes and HIV. It is also engaged in exploring dendrimer opportunities in materials science with applications in various areas, such as cosmetics, agrochemicals, and coatings. The company was founded in 1996 and is headquartered in Melbourne, Australia.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Starpharma Holdings Limited

Key Executives 
Dr. Jacinth K. Fairley B.Sc., B.V.Sc.(Hons), MBA, 51
Chief Exec. Officer and Exec. Director
Mr. Nigel J. Baade B.Com, CPA, Grad. Dip. Arts,
Chief Financial Officer and Company Sec.
Dr. Jeremy R. Paull BSc (Hons), Ph.D.,
VP of Devel. & Regulatory Affairs
Dr. C. Paul Barrett B.Sc. (Hons), Ph.D.,
VP of Bus. Devel.
Dr. David J. Owen BSc(Hons) Ph.D.,
VP of Research
Amounts are as of Dec 31, 2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.